These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984 [TBL] [Abstract][Full Text] [Related]
5. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics. Orta L; Klimstra DS; Qin J; Mecca P; Tang LH; Busam KJ; Shia J Am J Surg Pathol; 2009 Jun; 33(6):934-44. PubMed ID: 19342947 [TBL] [Abstract][Full Text] [Related]
6. The frequency of Muir-Torre syndrome among Lynch syndrome families. South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343 [TBL] [Abstract][Full Text] [Related]
7. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634 [TBL] [Abstract][Full Text] [Related]
8. Performance of Lynch syndrome predictive models in a multi-center US referral population. Khan O; Blanco A; Conrad P; Gulden C; Moss TZ; Olopade OI; Kupfer SS; Terdiman J Am J Gastroenterol; 2011 Oct; 106(10):1822-7; quiz 1828. PubMed ID: 21747416 [TBL] [Abstract][Full Text] [Related]
9. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622 [TBL] [Abstract][Full Text] [Related]
10. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273 [TBL] [Abstract][Full Text] [Related]
11. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827 [TBL] [Abstract][Full Text] [Related]
12. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. Kastrinos F; Ojha RP; Leenen C; Alvero C; Mercado RC; Balmaña J; Valenzuela I; Balaguer F; Green R; Lindor NM; Thibodeau SN; Newcomb P; Win AK; Jenkins M; Buchanan DD; Bertario L; Sala P; Hampel H; Syngal S; Steyerberg EW; J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582061 [TBL] [Abstract][Full Text] [Related]
14. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884 [TBL] [Abstract][Full Text] [Related]
15. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Barrow E; Robinson L; Alduaij W; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG Clin Genet; 2009 Feb; 75(2):141-9. PubMed ID: 19215248 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281 [TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree. Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566 [TBL] [Abstract][Full Text] [Related]
19. Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment. Jensen LH; Dysager L; Lindebjerg J; Kølvrå S; Byriel L; Crüger DG Eur J Cancer; 2010 Jul; 46(10):1823-8. PubMed ID: 20417091 [TBL] [Abstract][Full Text] [Related]
20. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]